Identification of a novel SARS-CoV-2 P.1 sub-lineage in Brazil provides new insights about the mechanisms of emergence of variants of concern

Detalhes bibliográficos
Autor(a) principal: Gräf, Tiago
Data de Publicação: 2021
Outros Autores: Bello, Gonzalo, Venas, Taina Moreira Martins, Pereira, Elisa Cavalcante, Paixão, Anna Carolina Dias, Appolinario, Luciana Reis, Lopes, Renata Serrano, Mendonça, Ana Carolina da Fonseca, Rocha, Alice Sampaio Barreto da, Motta, Fernando Couto, Gregianini, Tatiana Schäffer, Salvato, Richard Steiner, Fernandes, Sandra Bianchini, Rovaris, Darcita Buerger, Cavalcanti, Andrea Cony, Leite, Anderson Brandão, Riediger, Irina, Debur, Maria do Carmo, Bernardes, André Felipe Leal, Rodrigues, Rodrigo Ribeiro, Grinsztejn, Beatriz, Nascimento, Valdinete Alves do, Souza, Victor Costa de, Gonçalves, Luciana, Costa, Cristiano Fernandes da, Mattos, Tirza, Dezordi, Filipe Zimmer, Resende, Paola Cristina, Fiocruz COVID-19 Genomic Surveillance Network
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da FIOCRUZ (ARCA)
Texto Completo: https://www.arca.fiocruz.br/handle/icict/50917
Resumo: One of the most remarkable severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOC) features is the significant number of mutations they acquired. However, the specific factors that drove the emergence of such variants since the second half of 2020 are not fully resolved. In this study, we describe a new SARS-CoV-2 P.1 sub-lineage circulating in Brazil, denoted here as Gamma-like-II, that as well as the previously described lineage Gamma-like-I shares several lineage-defining mutations with the VOC Gamma. Reconstructions of ancestor sequences support that most lineage-defining mutations of the Spike (S) protein, including those at the receptor-binding domain (RBD), accumulated at the first P.1 ancestor. In contrast, mutations outside the S protein were mostly fixed at subsequent steps. Our evolutionary analyses estimate that P.1-ancestral strains carrying RBD mutations of concern probably circulated cryptically in the Amazonas for several months before the emergence of the VOC Gamma. Unlike the VOC Gamma, the other P.1 sub-lineages displayed a much more restricted dissemination and accounted for a low fraction (<2 per cent) of SARS-CoV-2 infections in Brazil in 2021. The stepwise diversification of lineage P.1 through multiple inter-host transmissions is consistent with the hypothesis that partial immunity acquired from natural SARS-CoV-2 infections in heavily affected regions might have been a major driving force behind the natural selection of some VOCs. The lag time between the emergence of the P.1 ancestor and the expansion of the VOC Gamma and the divergent epidemic trajectories of P.1 sub-lineages support a complex interplay between the emergence of mutations of concern and viral spread in Brazil.
id CRUZ_13dd78a658c859a4d55bef1f01186548
oai_identifier_str oai:www.arca.fiocruz.br:icict/50917
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Gräf, TiagoBello, GonzaloVenas, Taina Moreira MartinsPereira, Elisa CavalcantePaixão, Anna Carolina DiasAppolinario, Luciana ReisLopes, Renata SerranoMendonça, Ana Carolina da FonsecaRocha, Alice Sampaio Barreto daMotta, Fernando CoutoGregianini, Tatiana SchäfferSalvato, Richard SteinerFernandes, Sandra BianchiniRovaris, Darcita BuergerCavalcanti, Andrea ConyLeite, Anderson BrandãoRiediger, IrinaDebur, Maria do CarmoBernardes, André Felipe LealRodrigues, Rodrigo RibeiroGrinsztejn, BeatrizNascimento, Valdinete Alves doSouza, Victor Costa deGonçalves, LucianaCosta, Cristiano Fernandes daMattos, TirzaDezordi, Filipe ZimmerResende, Paola CristinaFiocruz COVID-19 Genomic Surveillance Network2022-01-27T17:30:49Z2022-01-27T17:30:49Z2021GRÄF, Tiago et al. Identification of a novel SARS-CoV-2 P.1 sub-lineage in Brazil provides new insights about the mechanisms of emergence of variants of concern. Virus Evolution, v. 7, n. 2, p. 1-10, 2021.2057-1577https://www.arca.fiocruz.br/handle/icict/5091710.1093/ve/veab091One of the most remarkable severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOC) features is the significant number of mutations they acquired. However, the specific factors that drove the emergence of such variants since the second half of 2020 are not fully resolved. In this study, we describe a new SARS-CoV-2 P.1 sub-lineage circulating in Brazil, denoted here as Gamma-like-II, that as well as the previously described lineage Gamma-like-I shares several lineage-defining mutations with the VOC Gamma. Reconstructions of ancestor sequences support that most lineage-defining mutations of the Spike (S) protein, including those at the receptor-binding domain (RBD), accumulated at the first P.1 ancestor. In contrast, mutations outside the S protein were mostly fixed at subsequent steps. Our evolutionary analyses estimate that P.1-ancestral strains carrying RBD mutations of concern probably circulated cryptically in the Amazonas for several months before the emergence of the VOC Gamma. Unlike the VOC Gamma, the other P.1 sub-lineages displayed a much more restricted dissemination and accounted for a low fraction (<2 per cent) of SARS-CoV-2 infections in Brazil in 2021. The stepwise diversification of lineage P.1 through multiple inter-host transmissions is consistent with the hypothesis that partial immunity acquired from natural SARS-CoV-2 infections in heavily affected regions might have been a major driving force behind the natural selection of some VOCs. The lag time between the emergence of the P.1 ancestor and the expansion of the VOC Gamma and the divergent epidemic trajectories of P.1 sub-lineages support a complex interplay between the emergence of mutations of concern and viral spread in Brazil.Fundação Oswaldo Cruz. Instituto Gonçalo Muniz. Plataforma de Vigilância Molecular. Salvador, BA, Brasil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de AIDS e Imunologia Molecular. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Vírus Respiratórios e do Sarampo. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Vírus Respiratórios e do Sarampo. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Vírus Respiratórios e do Sarampo. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Vírus Respiratórios e do Sarampo. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Vírus Respiratórios e do Sarampo. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Vírus Respiratórios e do Sarampo. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Vírus Respiratórios e do Sarampo. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Vírus Respiratórios e do Sarampo. Rio de Janeiro, RJ, Brasil.Laboratório Central de Saúde Pública do Estado do Rio Grande do Sul. Porto Alegre, RS, Brasil.Laboratório Central de Saúde Pública do Estado do Rio Grande do Sul. Porto Alegre, RS, Brasil.Laboratório Central de Saúde Pública do Estado de Santa Catarina, Florianópolis, SC, Brasil.Laboratório Central de Saúde Pública do Estado de Santa Catarina, Florianópolis, SC, Brasil.Laboratório Central de Saúde Pública do Estado do Rio de Janeiro. Rio de Janeiro, RJ, Brasil.Laboratório Central de Saúde Pública do Estado de Alagoas. Maceió. AL, Brasil.Laboratório Central de Saúde Pública do Estado do Paraná. Curitiba, PR, Brasil.Laboratório Central de Saúde Pública do Estado do Paraná. Curitiba, PR, Brasil.Laboratório Central de Saúde Pública do Estado de Minas Gerais. Belo Horizonte, MG, Brasil.Laboratório Central de Saúde Pública do Estado do Espírito Santo. Vitória, ES, Brasil.Fundação Oswaldo Cruz. Instituto Nacional de Infectologia. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Leônidas e Maria Deane. Laboratório de Ecologia de Doenças Transmissíveis na Amazônia. Manaus AM, Brasil.Fundação Oswaldo Cruz. Instituto Leônidas e Maria Deane. Laboratório de Ecologia de Doenças Transmissíveis na Amazônia. Manaus AM, Brasil.Fundação Oswaldo Cruz. Instituto Leônidas e Maria Deane. Laboratório de Ecologia de Doenças Transmissíveis na Amazônia . Manaus AM, Brasil.Fundação de Vigilância em Saúde do Amazonas. Manaus, AM, Brasil.Laboratório Central de Saúde Pública do Amazonas. Manaus, AM, Brasil.Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Departamento de Entomologia. Recife, PE, Brasil / Fundação Oswaldo Cruz. Instituto Aggeu Magalhães, Núcleo de Bioinformática, Recife, PE, Brasil.Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Departamento de Entomologia. Recife, PE, Brasil / Fundação Oswaldo Cruz. Instituto Aggeu Magalhães, Núcleo de Bioinformática, Recife, PE, Brasil.Fundação Oswaldo Cruz. Instituto Leônidas e Maria Deane. Laboratório de Ecologia de Doenças Transmissíveis na Amazônia. Manaus AM, Brasil.Universidade Federal do Espírito Santo. Centro de Ciências Exatas, Naturais e da Saúde. Departamento de BioGRäflogia. Alegre, ES, Brasil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Vírus Respiratórios e do Sarampo. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Vírus Respiratórios e do Sarampo. Rio de Janeiro, RJ, Brasil.Fiocruz COVID-19 Genomic Surveillance NetworkengOxford University PressSARS-CoV-2Vigilância genômicaVariante de preocupação GamaLinhagem P.1BrasilSARS-CoV-2Genomic surveillanceVariant of concern GammaBrazilLineage P.1Identification of a novel SARS-CoV-2 P.1 sub-lineage in Brazil provides new insights about the mechanisms of emergence of variants of concerninfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-82991https://www.arca.fiocruz.br/bitstream/icict/50917/1/license.txt5a560609d32a3863062d77ff32785d58MD51ORIGINALGonzaloBello_AnaCPaixão_etal_IOC_2021.pdfGonzaloBello_AnaCPaixão_etal_IOC_2021.pdfapplication/pdf1316086https://www.arca.fiocruz.br/bitstream/icict/50917/2/GonzaloBello_AnaCPaix%c3%a3o_etal_IOC_2021.pdf67bc6ea7d66f2249fb520f2b106a1eacMD52icict/509172022-12-02 19:36:34.848oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352022-12-02T22:36:34Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.pt_BR.fl_str_mv Identification of a novel SARS-CoV-2 P.1 sub-lineage in Brazil provides new insights about the mechanisms of emergence of variants of concern
title Identification of a novel SARS-CoV-2 P.1 sub-lineage in Brazil provides new insights about the mechanisms of emergence of variants of concern
spellingShingle Identification of a novel SARS-CoV-2 P.1 sub-lineage in Brazil provides new insights about the mechanisms of emergence of variants of concern
Gräf, Tiago
SARS-CoV-2
Vigilância genômica
Variante de preocupação Gama
Linhagem P.1
Brasil
SARS-CoV-2
Genomic surveillance
Variant of concern Gamma
Brazil
Lineage P.1
title_short Identification of a novel SARS-CoV-2 P.1 sub-lineage in Brazil provides new insights about the mechanisms of emergence of variants of concern
title_full Identification of a novel SARS-CoV-2 P.1 sub-lineage in Brazil provides new insights about the mechanisms of emergence of variants of concern
title_fullStr Identification of a novel SARS-CoV-2 P.1 sub-lineage in Brazil provides new insights about the mechanisms of emergence of variants of concern
title_full_unstemmed Identification of a novel SARS-CoV-2 P.1 sub-lineage in Brazil provides new insights about the mechanisms of emergence of variants of concern
title_sort Identification of a novel SARS-CoV-2 P.1 sub-lineage in Brazil provides new insights about the mechanisms of emergence of variants of concern
author Gräf, Tiago
author_facet Gräf, Tiago
Bello, Gonzalo
Venas, Taina Moreira Martins
Pereira, Elisa Cavalcante
Paixão, Anna Carolina Dias
Appolinario, Luciana Reis
Lopes, Renata Serrano
Mendonça, Ana Carolina da Fonseca
Rocha, Alice Sampaio Barreto da
Motta, Fernando Couto
Gregianini, Tatiana Schäffer
Salvato, Richard Steiner
Fernandes, Sandra Bianchini
Rovaris, Darcita Buerger
Cavalcanti, Andrea Cony
Leite, Anderson Brandão
Riediger, Irina
Debur, Maria do Carmo
Bernardes, André Felipe Leal
Rodrigues, Rodrigo Ribeiro
Grinsztejn, Beatriz
Nascimento, Valdinete Alves do
Souza, Victor Costa de
Gonçalves, Luciana
Costa, Cristiano Fernandes da
Mattos, Tirza
Dezordi, Filipe Zimmer
Resende, Paola Cristina
Fiocruz COVID-19 Genomic Surveillance Network
author_role author
author2 Bello, Gonzalo
Venas, Taina Moreira Martins
Pereira, Elisa Cavalcante
Paixão, Anna Carolina Dias
Appolinario, Luciana Reis
Lopes, Renata Serrano
Mendonça, Ana Carolina da Fonseca
Rocha, Alice Sampaio Barreto da
Motta, Fernando Couto
Gregianini, Tatiana Schäffer
Salvato, Richard Steiner
Fernandes, Sandra Bianchini
Rovaris, Darcita Buerger
Cavalcanti, Andrea Cony
Leite, Anderson Brandão
Riediger, Irina
Debur, Maria do Carmo
Bernardes, André Felipe Leal
Rodrigues, Rodrigo Ribeiro
Grinsztejn, Beatriz
Nascimento, Valdinete Alves do
Souza, Victor Costa de
Gonçalves, Luciana
Costa, Cristiano Fernandes da
Mattos, Tirza
Dezordi, Filipe Zimmer
Resende, Paola Cristina
Fiocruz COVID-19 Genomic Surveillance Network
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Gräf, Tiago
Bello, Gonzalo
Venas, Taina Moreira Martins
Pereira, Elisa Cavalcante
Paixão, Anna Carolina Dias
Appolinario, Luciana Reis
Lopes, Renata Serrano
Mendonça, Ana Carolina da Fonseca
Rocha, Alice Sampaio Barreto da
Motta, Fernando Couto
Gregianini, Tatiana Schäffer
Salvato, Richard Steiner
Fernandes, Sandra Bianchini
Rovaris, Darcita Buerger
Cavalcanti, Andrea Cony
Leite, Anderson Brandão
Riediger, Irina
Debur, Maria do Carmo
Bernardes, André Felipe Leal
Rodrigues, Rodrigo Ribeiro
Grinsztejn, Beatriz
Nascimento, Valdinete Alves do
Souza, Victor Costa de
Gonçalves, Luciana
Costa, Cristiano Fernandes da
Mattos, Tirza
Dezordi, Filipe Zimmer
Resende, Paola Cristina
Fiocruz COVID-19 Genomic Surveillance Network
dc.subject.other.pt_BR.fl_str_mv SARS-CoV-2
Vigilância genômica
Variante de preocupação Gama
Linhagem P.1
Brasil
topic SARS-CoV-2
Vigilância genômica
Variante de preocupação Gama
Linhagem P.1
Brasil
SARS-CoV-2
Genomic surveillance
Variant of concern Gamma
Brazil
Lineage P.1
dc.subject.en.pt_BR.fl_str_mv SARS-CoV-2
Genomic surveillance
Variant of concern Gamma
Brazil
Lineage P.1
description One of the most remarkable severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOC) features is the significant number of mutations they acquired. However, the specific factors that drove the emergence of such variants since the second half of 2020 are not fully resolved. In this study, we describe a new SARS-CoV-2 P.1 sub-lineage circulating in Brazil, denoted here as Gamma-like-II, that as well as the previously described lineage Gamma-like-I shares several lineage-defining mutations with the VOC Gamma. Reconstructions of ancestor sequences support that most lineage-defining mutations of the Spike (S) protein, including those at the receptor-binding domain (RBD), accumulated at the first P.1 ancestor. In contrast, mutations outside the S protein were mostly fixed at subsequent steps. Our evolutionary analyses estimate that P.1-ancestral strains carrying RBD mutations of concern probably circulated cryptically in the Amazonas for several months before the emergence of the VOC Gamma. Unlike the VOC Gamma, the other P.1 sub-lineages displayed a much more restricted dissemination and accounted for a low fraction (<2 per cent) of SARS-CoV-2 infections in Brazil in 2021. The stepwise diversification of lineage P.1 through multiple inter-host transmissions is consistent with the hypothesis that partial immunity acquired from natural SARS-CoV-2 infections in heavily affected regions might have been a major driving force behind the natural selection of some VOCs. The lag time between the emergence of the P.1 ancestor and the expansion of the VOC Gamma and the divergent epidemic trajectories of P.1 sub-lineages support a complex interplay between the emergence of mutations of concern and viral spread in Brazil.
publishDate 2021
dc.date.issued.fl_str_mv 2021
dc.date.accessioned.fl_str_mv 2022-01-27T17:30:49Z
dc.date.available.fl_str_mv 2022-01-27T17:30:49Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv GRÄF, Tiago et al. Identification of a novel SARS-CoV-2 P.1 sub-lineage in Brazil provides new insights about the mechanisms of emergence of variants of concern. Virus Evolution, v. 7, n. 2, p. 1-10, 2021.
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/50917
dc.identifier.issn.pt_BR.fl_str_mv 2057-1577
dc.identifier.doi.none.fl_str_mv 10.1093/ve/veab091
identifier_str_mv GRÄF, Tiago et al. Identification of a novel SARS-CoV-2 P.1 sub-lineage in Brazil provides new insights about the mechanisms of emergence of variants of concern. Virus Evolution, v. 7, n. 2, p. 1-10, 2021.
2057-1577
10.1093/ve/veab091
url https://www.arca.fiocruz.br/handle/icict/50917
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Oxford University Press
publisher.none.fl_str_mv Oxford University Press
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/50917/1/license.txt
https://www.arca.fiocruz.br/bitstream/icict/50917/2/GonzaloBello_AnaCPaix%c3%a3o_etal_IOC_2021.pdf
bitstream.checksum.fl_str_mv 5a560609d32a3863062d77ff32785d58
67bc6ea7d66f2249fb520f2b106a1eac
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1813009110310846464